CY1116137T1 - Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας - Google Patents

Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας

Info

Publication number
CY1116137T1
CY1116137T1 CY20151100290T CY151100290T CY1116137T1 CY 1116137 T1 CY1116137 T1 CY 1116137T1 CY 20151100290 T CY20151100290 T CY 20151100290T CY 151100290 T CY151100290 T CY 151100290T CY 1116137 T1 CY1116137 T1 CY 1116137T1
Authority
CY
Cyprus
Prior art keywords
inhibitors
disorders
subsyclosure
hypersensitivity
medicament
Prior art date
Application number
CY20151100290T
Other languages
English (en)
Inventor
Yolande Chvatchko
Marie Kosco-Vilbois
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of CY1116137T1 publication Critical patent/CY1116137T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Η εφεύρεση αφορά στη χρήση αναστολέων της IL-18 στην παρασκευή ενός φαρμάκου για θεραπεία ή/και πρόληψη διαταραχών υπερευαισθησίας και ιδιαιτέρως υπερευαισθησίας καθυστερημένου-τύπου.
CY20151100290T 2001-08-10 2015-03-23 Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας CY1116137T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01118811 2001-08-10
EP02100735 2002-06-20
EP02767299.7A EP1423138B1 (en) 2001-08-10 2002-08-01 Use of il-18 inhibitors in hypersensitivity disorders

Publications (1)

Publication Number Publication Date
CY1116137T1 true CY1116137T1 (el) 2017-02-08

Family

ID=26076673

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100290T CY1116137T1 (el) 2001-08-10 2015-03-23 Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας

Country Status (27)

Country Link
US (1) US20040247598A1 (el)
EP (1) EP1423138B1 (el)
JP (1) JP4301942B2 (el)
KR (1) KR20040030948A (el)
CN (1) CN100500210C (el)
AR (1) AR035274A1 (el)
AU (1) AU2002331376B2 (el)
BR (1) BRPI0211827B8 (el)
CA (1) CA2456247C (el)
CY (1) CY1116137T1 (el)
DK (1) DK1423138T3 (el)
EA (1) EA006745B1 (el)
ES (1) ES2533253T3 (el)
HK (1) HK1069780A1 (el)
HR (1) HRP20040071B1 (el)
HU (1) HU230377B1 (el)
IL (2) IL160230A0 (el)
ME (1) ME00547B (el)
MX (1) MXPA04001230A (el)
NO (1) NO335688B1 (el)
PL (1) PL227130B1 (el)
PT (1) PT1423138E (el)
RS (1) RS52224B (el)
SI (1) SI1423138T1 (el)
UA (1) UA78516C2 (el)
WO (1) WO2003013577A2 (el)
ZA (1) ZA200400442B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004683A1 (en) * 2004-06-30 2009-01-01 Atsuo Sekiyama Indicator Agent for Noninflammatory Stress Response and Use Thereof
ES2385639T3 (es) 2005-06-03 2012-07-27 Ares Trading S.A. Producción de una proteína de unión a IL-18 recombinante
WO2006131550A1 (en) 2005-06-10 2006-12-14 Ares Trading S.A. Process for the purification of il-18 binding protein
ES2514495T3 (es) 2006-05-25 2014-10-28 Glaxo Group Limited Anticuerpos humanizados modificados anti-interleucina-18
WO2012081650A1 (ja) * 2010-12-16 2012-06-21 株式会社明治 遅延型過敏症軽減剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
DE69925581T2 (de) * 1998-03-09 2006-04-27 Vertex Pharmaceuticals Inc., Cambridge 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
BR9816013A (pt) * 1998-09-01 2003-01-21 Hayashibara Biochem Lab Proteìna de ligação de interleucina-18
AU5282600A (en) * 1999-05-20 2000-12-12 Hyseq, Inc. Interleukin-1 hy2 materials and methods
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders

Also Published As

Publication number Publication date
EP1423138A2 (en) 2004-06-02
PT1423138E (pt) 2015-02-09
NO335688B1 (no) 2015-01-19
UA78516C2 (en) 2007-04-10
EP1423138B1 (en) 2014-12-24
PL227130B1 (pl) 2017-10-31
MXPA04001230A (es) 2004-05-27
HU230377B1 (hu) 2016-03-29
RS52224B (sr) 2012-10-31
WO2003013577A2 (en) 2003-02-20
HK1069780A1 (en) 2005-06-03
PL368231A1 (en) 2005-03-21
YU11904A (sh) 2006-08-17
SI1423138T1 (sl) 2015-04-30
ES2533253T3 (es) 2015-04-08
HUP0401323A3 (en) 2006-01-30
EA006745B1 (ru) 2006-04-28
ZA200400442B (en) 2005-03-30
BRPI0211827B1 (pt) 2019-07-23
BRPI0211827B8 (pt) 2021-05-25
IL160230A (en) 2014-11-30
US20040247598A1 (en) 2004-12-09
HUP0401323A2 (hu) 2004-10-28
HRP20040071B1 (hr) 2015-08-28
JP4301942B2 (ja) 2009-07-22
JP2005501080A (ja) 2005-01-13
ME00547B (me) 2011-12-20
CA2456247C (en) 2013-09-10
DK1423138T3 (en) 2015-02-23
AR035274A1 (es) 2004-05-05
CN1568193A (zh) 2005-01-19
KR20040030948A (ko) 2004-04-09
CA2456247A1 (en) 2003-02-20
HRP20040071A2 (en) 2004-10-31
NO20040370L (no) 2004-03-23
AU2002331376B2 (en) 2007-06-14
IL160230A0 (en) 2004-07-25
CN100500210C (zh) 2009-06-17
EA200400296A1 (ru) 2004-06-24
BR0211827A (pt) 2004-08-31
WO2003013577A3 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
CY1108748T1 (el) Χρηση αναστολεων της il-18 για την αντιμετωπιση και/η προληψη περιφερικων αγγειακων παθησεων
CY1116137T1 (el) Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας
CY1110385T1 (el) Χρηση αναστολεων της il-18 για τη θεραπεια και/ή προληψη της αθηροσκληρωσης
CY1116992T1 (el) Μεθοδος θεραπειας της σκληρυνσης κατα πλακας αναστελλοντας τη δραση της il-17
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
CY1114133T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ
NO20034056D0 (no) Proliferative sykdommer
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
CY1119190T1 (el) Χρηση αναστολεων της il-18 για αγωγη ή προληψη βλαβων του κνς
TR201907874T4 (tr) Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler.
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
CY1108661T1 (el) Αναστολεις ρ38 και μεθοδοι χρησης αυτων
CY1105429T1 (el) Φαρμακευτικη συνθεση συνδυαζουσα τενατοπραζολη και ενα αντιφλεγμονωδες
HRP20070552T3 (en) Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders
CY1114448T1 (el) Φαρμακευτικες συνθεσεις και χρηση αυτων στην αγωγη της γυναικειας σεξουαλικης δυσλειτουργιας
CY1107439T1 (el) Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
CY1111902T1 (el) Χρηση ακυλοφωσφοχολινων σε συνδυασμο με αντινεοπλασματικα φαρμακα
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
ATE439828T1 (de) In der mundhíhle dispergierbare feste pharmazeutische form
SE0302304D0 (sv) Novel compounds
CY1110043T1 (el) 2-αμινοβενζουλ παραγωγα
PA8571501A1 (es) Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
EA200501528A1 (ru) Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний